Table 1 Demographic characteristics of PD patients in the individual cohorts

From: Genome-wide association study of REM sleep behavior disorder in Parkinson’s disease

Center

PD + RBD, n

Age PD + RBD (SD)

%Fem PD + RBD

PD-RBD, n

Age PD-RBD (SD)

%Fem PD-RBD

Total

Oslo

130

65.6 (8.8)

25%

180

66.1 (10)

44%

310

Lund

365

71.4 (7)

39%

555

70.8 (9.2)

33%

920

McGill

285

67.4 (9.2)

31%

217

67 (8.8)

49%

502

AMP-PD

111

66.4 (9.4)

69%

269

65.5 (10.3)

62%

380

Sydney

105

59 (10.8)

32%

125

60 (10.7)

38%

230

Tuebingen

453

68.8 (9.1)

33%

659

67.7 (10.2)

38%

1112

Barcelona

133

69.5 (9.8)

44%

71

74.3 (10)

66%

204

PRoBaND

585

67.3 (8.9)

30%

1134

67.7 (9.3)

38%

1719

PFP

257

62.4 (12.5)

37%

339

61.4 (13)

47%

596

OPDC

274

67.3 (9.3)

27%

539

67.4 (9.6)

38%

813

Kosice

102

71.4 (8.3)

33%

225

69.2 (10.7)

42%

327

23andMe

2603

NAa

38%

8707

NAa

45%

11,310

Total

5403

/

/

13,020

/

/

18,423

  1. PD+RBD, n number of Parkinson’s disease patients with REM sleep behavior disorder, PD-RBD, n number of Parkinson’s disease patients without REM sleep behavior disorder, Age mean age in the group, SD standard deviation, %Fem percentage of females, Tot total number of PD patients in the cohort, Oslo Oslo University Hospital, Lund Lund University, McGill McGill University, AMP-PD Accelerating Medicines Partnership Parkinson’s disease, including the New Discovery of Biomarkers (BioFIND), the Harvard Biomarker Study (HBS) and the Parkinson’s Disease Biomarkers Program (PDBP) cohorts, Sydney University of Sydney, Tuebingen University of Tuebingen, Barcelona Hospital Universitari Mutua de Terrassa, PRoBaND Parkinson’s repository of biosamples and networked datasets, PFP Parkinson’s Families Project, OPDC Oxford Parkinson’s Disease Centre, Kosice Pavol Jozef Šafárik University in Kosice.
  2. a23andMe only provides age ranges (i.e., in cases: 5 individuals <30 years of age, 49 individuals 30–45, 346 individuals 45–60, 2203 individuals >60; in controls: 11 individuals <30, 146 individuals 30–45, 1302 individuals 45–60, 7248 individuals >60).